medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2023, Number 3

<< Back Next >>

Rev ADM 2023; 80 (3)

Unicystic ameloblastoma with a plexiform pattern. Literature review regarding a clinical case.

Landa RC, Gómez PFJ

Language: Spanish
References: 46
Page: 151-159
PDF size: 393.03 Kb.


ABSTRACT

In 1827, physician James William Cusack described an expansive tumor lesion with clinical characteristics similar to ameloblastoma. For 2017, the World Health Organization classified it as a benign odontogenic tumor of epithelial origin. Currently, we have accepted the theory of its etiology associated with a mutation in the BRAF-V600E biomarker, where there are clear extra/intratumoral heterogeneities in the metabolism of tumorigenesis; the BRAF mutation generates changes in the regulation of odontogenesis, together with the CDC73 gene present on chromosome 1 q25-q32, producing a change in the parafibromin protein that inhibits cell proliferation during cell growth and division, which together it affects the p53 gene and its p63 homolog is present on chromosome 17, resulting in the expression of dental cysts and tumors such as ameloblastoma. This work provides the clinical case of an 11-year-old patient with an increase in volume in the left submandibular region of 7 × 4 cm of 6 years of evolution. Being diagnosed as a unicistic ameloblastoma and treated conservatively by enucleation, it is subsequently evaluated annually until the patient reaches 18 years of age.


REFERENCES

  1. Cusack JW. Report of the amputations of the lower jaw. Dublin Hosp Rec. 1827; 4: 1-38.

  2. Parker JW. Popular science and journal of the useful arts. John W. Parker, London y 1836, p. 256.

  3. The presidents of the college under the second chapter 1829-1844. Chapter XIX (Internet). 1917. (Cited 13 April 2020) Recovered from: http://www.rcsi.ie/files/library/docs/20161220113717_History%20of%20the%20RCSI%20-%20chapter%20.pdf

  4. Malassez L. Sur Le role des debris epitheliaux papdentaires. Arch Physiol Norm Pathol. 1885; 5 (6): 309-340.

  5. Basat OS, Oreroglu RA, Orman C, Aksan T, Uscetin L, Akan M. Recurrent ameloblastoma in the free fibula flap: review of literature and an unusual case report. J Maxillofac Oral Surg. 2015; 14 (3): 821-825.

  6. Sehdev MK, Huvos AG, Strong EW, Gerold FP, Willis GW. Ameloblastoma of maxilla and mandible. Cancer. 1974; 2 (33): 324-333.

  7. Ivery RH, Churchill L. The need for a standardized surgical and pathological classification of tumors and anomalies of dental origin. Am Assoc Dent Sch Trans. 1930; 7: 240-245.

  8. World Health Organization (WHO). WHO Classification of head and neck tumours. IARC Press: Lyon 2017.

  9. Bhuyan SK, Bhuyan R, Sahoo TK, Das P. Recurrence of plexiform ameloblastoma as acanthomatous ameloblastoma: a rare case report. Contemp Clin Dent. 2019; 10 (1): 178-181.

  10. Mendenhall MW, Werning WJ, Rui F, Malyapa SR, Mendenhall PN. Ameloblastoma. Am J Clin Oncol. 2007; 30 (6): 645-648.

  11. Alcívar-Giler LM. Prevalencia de ameloblastomas en el Hospital Teodoro Maldonado Carbo 2013-2018. (Tesis en Internet) (Ecuador): Facultad de Odontología, Universidad de Guayaquil;2019. (Citado 13 de abril 2020). Recuperado de: http://repositorio.ug.edu.ec/bitstream/redug/39935/1/ALCIVARpesantes.pdf

  12. Agani Z, Hamiti KV, Recica J, Prekazi LM, Kurshuliu F, Rexhepi A. Maxillary unicystic ameloblastoma: a case report. BMC Research Notes. 2016; 9 (469): 2-4.

  13. Heikinheimo K, Huhtala JM, Thiel A. The mutational profile of unicystic ameloblastoma. J Dent Res. 2019; 98 (1): 54-60.

  14. Apellániz D, Pereira PV, Sicco E. Comparative study of the minichromosome maintenance complex (MCM 4/5/6) in ameloblastoma and unicystic ameloblastoma. Int J Surg Pathol. 2018; 26 (8): 714-720.

  15. Gupta R, Chaudhary M, Patil S, Fating C, Hande A, Suryawanshi H. Expression of p63 in tooth germ, dentigerous cyst and ameloblastoma. J Oral Maxillofac Pathol. 2019; 23 (1): 43-48.

  16. Palma C, Munzenmayer J, Barrientos G, Garrido V, Bravo C, Moscoso C, Valenzuela A. Conservative treatment of unicystic plexiform ameloblastoma: case report with 6 years of follow-up. Oral & Maxillofacial Surgery. 2019; 48 (1): 239.

  17. Duarte-Andrade FF, Barbosa-Silva AM, Gardone VJ, Baptista-Canuto GA, Santos- Costa SF, Goncalves DM. The importance of BRAF-V600E mutation to ameloblastoma metabolism. J Oral Pathol Med. 2019; 48 (4): 307-314.

  18. Carlson RE, Marx ER. The ameloblastoma: primary, curative surgical management. J Oral Maxillofac Surg. 2006; 64 (3): 484-494.

  19. Guan P, Wong SF, Lim JQ, Soong PL, Sim CQ et al. Mutational signatures in mandibular ameloblastoma correlate with smoking. J Dent Res. 2019; 98 (6): 652-658.

  20. Shaaban MN, Ali HM, Kumar SP, Jabbar-Abdulqadir OA, Rahim AA. Recurring peripheral ameloblastoma at mandibular premolar region: a case report. Dentomaxillofac Radiol. 2007; 36 (3): 183-186.

  21. Singh M, Sajeev E, Prabakaran M. Ameloblastoma of mandible. Global Journal for Research Analysis. 2019; 8 (6): 18.

  22. Sia C, Pangan R. Conservative treatment protocol for ameloblastoma of the mandible. International Journal of Oral & Maxillofacila Surgery. 2019; 48(1): 103-104.

  23. Jueyoung K, Jinsun K, Shadavlonjid B, Sung-won C, Jin K. OPG and BCL-2 Promote ameloblastoma cell tumorigenesis and predict prognosis for ameloblastoma patients. Oral Surgery Oral Medicine Oral Pathology Oral Radiology. 2019; 128 (1): 58.

  24. Masthan MK, Anitha N, Krupaa J, Manikkam S. Ameloblastoma. J Pharm Bioallied Sci. 2015; 7 (1): 167-170.

  25. Kitisubkanchana J, Reduwan NH, Poomsawat S, Pornprasertsuk-Damrongsri S, Wongchuensoontorn C. Odontogenic keratocyst and ameloblastoma: radiographic evaluation. Oral Radiol. 2020; doi: 10.1007/s11282-020-00425-2.

  26. Regezi AJ, Sciubba JJ. Patología buccal. 3er. ed. California: Mc Graw-Hill Interamericana. 2000.

  27. Dellán A, Villarroel DM, Hernández AA. Aplicación de las unidades Hounsfield en tomografía Computarizada como herramienta diagnóstica de las lesiones intra-óseas del complejo maxilo-mandibular: estudio clínico de diagnóstico. Rev Odontol Univ Cid Sao Paulo. 2015; 27 (2): 100-111.

  28. Haripriya P, Ananthaneni A, Guduru VS, Horatti PK, Kiresur MA, Vara JT. Collagen during odontogenesis and in ameloblastoma: a polarizing microscopic study. J Oral Maxillofac Pathol. 2019; 23 (3): 474.

  29. Tate GJ, Bamford S, Jubb HC, Sondka Z, Beare MD, Bindal N et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Research. 2019; 47: 941-947.

  30. Oliva R, Ballesta F, Oriola J, Clária J. Genética médica. España: Díaz de Santos. 2008.

  31. Ramírez MA, Saavedra A, Rojas MR, Rojas GA. Expresión inmunohistoquímica de Ki-67 y p53 en tumor odontogénico queratoquístico en comparación con ameloblastoma multiquístico. Rev Clin Periodoncia Implantol. Rehabil Oral. 2014; 7 (1): 12-16.

  32. Browm AN, Betz LB. Ameloblastoma: a review of recent molecular pathogenetic discoveries. Biomark Cancer. 2015; 7 (2): 19-24.

  33. Peña-Vega JL. Biomarcadores relacionados con el ameloblastoma. Actualización de la literatura. (Tesis en Internet). (Sevilla): Facultad de Odontología, Universidad de Sevilla; 2018. (Citado 13 de abril del 2020) Recuperado de: https://idus.us.es/bitstream/handle/11441/78533/TFM%2044.pdf?sequence=1&isAllowed=y

  34. Gallardo-Neira AA. Niveles de receptor activador del factor nuclear KB, ligando de RANK y osteoprotegerina en casos de ameloblastomas, tumor odontogénico queratoquístico y quiste dentígero. (Tesis en Internet). (Chile): Facultad de odontología, Universidad de Chile; 2017. (Citado 13 de abril del 2020) Recuperado de: http://repositorio.uchile.cl/bitstream/handle/2250/147474/Niveles-del-receptor-activador-del-factor-nuclear-kB-%20ligando-de-RANK.pdf?sequence=1&isAllowed=y

  35. Martín HF. Evaluación de la expresión de Ciclina D1, COX-2, Actina y Ki-67 en queratoquiste odontogénico, quiste odontogénico ortoqueratizado y ameloblastoma de los maxilares y sus implicaciones diagnósticas y patogénicas. (Tesis en Internet). (Madrid): Facultad de Odontología, Universidad Complutense de Madrid; 2019. (Citado 13 de abril del 2020) Recuperado de: https://eprints.ucm.es/58866/1/T41640.pdf

  36. Vanje MM, Tanveer S, Ahmed SA, Kumar S, Vanje T. Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma. J Oral Maxillofac Pathol. 2019; 23 (3): 400-406.

  37. CD44.CD44 (internet). Conganat.org. Universidad de Las Palmas de Gran Canaria. (Citado 13 de abril del 2020) Recuperado de: http://www.conganat.org/icongreso/conferencias/009/cd44.htm

  38. Chen L, Wang G, Qiao X, Wang X, Liu J, Niu X, Zhong M. Downregulated miR-5245p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis. Med Sci Monit. 2020; 26: 10.12659/MSM.921863.

  39. Peralta S, Angela L, Mc Cleary-Wheeler, Duhamel EG, Heikinheimo K, Grenier KJ. Ultra-frequent HRAS p-Q61R somatic mutation in canince acanthomatous ameloblastoma reveals pathogenic similarities with human ameloblastoma. Vet Comp Oncol. 2019; 17 (3): 439-445.

  40. Aadithya B, Singh H, Verme M. Genetic Polymorphism and gene expression of P13K gene in ameloblastoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2019; 128 (1): 89.

  41. Silva BS, Silva LR, Lima KL, Dos Santos AC, Dezzen-Gomide AC, Batista AC, Yamamoto-Silva FP. SSOX2 and BCL.2 Expressions in odontogenic keratocyst and ameloblastoma. Med Oral Patol Oral Cir Bucal. 2020; 25 (2): 283-290.

  42. Munévar-Niño JC, Becerra-Calixto A, Bermúdez OC. Aspectos celulares y moleculares de las células madres involucradas en la regeneración del tejido con aplicaciones en la práctica clínica odontológica. Acta odontol. Venez. 2008; 46 (3): 361-369.

  43. García GV, González-Moles MA, Bascones MA. Expresión de bcl-2, Ki-67 y caspasa-3 en lesiones cancerosas de la mucosa oral. Resultados preliminares. Av Odontoestomatol. 2006; 22 (5): 263-269.

  44. Stolbizer F, Hernández S, Andrada MM, Villegas KM, Drago A, Vázquez D et al. Methodology to evaluate the conservative treatment of the intrabony mandibular ameloblastoma. International Journal of Oral & Maxillofacial Surgery. 2019; 48 (1): 276.

  45. Matsuda S, Yoshimura H, Yoshida H, Imamura Y, Ueno T, Son K. Three-dimensional volumetric analysis of unicystic ameloblastoma before and after marsupialization using osirix software. Journal of Hard Tissue Biology. 2019; 28 (2): 233-236.

  46. Torres LD, Infante CP, Hernández-Guisado JM, Gutiérrez-Pérez JL. Ameloblastoma mandibular. Revisión de la literatura y presentación de seis casos. Med Oral Patol Oral Cir Bucal. 2005; 10 (3): 231-238.




2020     |     www.medigraphic.com